Patients were randomly assigned to receive daily subcutaneous injections of replacement ... The authors conclude that C-peptide treatment at a replacement dose for 6 months improves early ...
"Often, you don't know whether the bacteria that caused a wound infection are resistant to a certain antibiotic when you start treatment. Applying the peptide material to the wound simultaneously ...
Sciwind has granted Verdiva the exclusive global rights to develop, manufacture and commercialize the partnered programs outside of greater China and South Korea. Sciwind has retained the rights to ...
Researchers at IIT Guwahati and Bose Institute Kolkata have developed an innovative injectable hydrogel for targeted breast cancer therapy. This breakthrough enables precise drug delivery to tumours, ...